Skip to main content

Finasteride

FDA recalls

2 rows

DateCompany and reasonClass
Feb 6, 2023Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Terminated
Dec 28, 2016Hetero Drugs Ltd. - Unit 1
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Class III · Terminated

← Back to Finasteride

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).